Ajanta Pharma Limited

NSE:AJANTPHARM.NS

3198.5 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12012 Q42012 Q32012 Q22012 Q1
Revenue 11,449.210,540.811,051.510,284.410,210.48,818.49,717.79,3819,509.38,134.38,379.18,8487,479.97,141.77,487.47,159.16,6826,558.96,512.16,427.66,119.44,762.44,851.15,441.15,109.95,303.15,870.55,403.84,731.24,768.15,331.15,158.24,710.24,3064,727.84,376.73,913.53,536.24,078.53,718.73,217.40000
Cost of Revenue 5,8565,321.42,941.72,561.22,5192,4092,693.32,597.52,804.22,937.71,890.62,322.31,716.62,052.51,686.81,553.61,5312,121.21,690.91,663.81,425.41,455.5978.9959.3841.3937.61,099.91,090.3936.3922.61,064.21,165.5993.6954.81,154.7995.21,033.61,107.31,013.1947.7794.10000
Gross Profit 5,593.25,219.48,109.87,723.27,691.46,409.47,024.46,783.56,705.15,196.66,488.56,525.75,763.35,089.25,800.65,605.55,1514,437.74,821.24,763.84,6943,306.93,872.24,481.84,268.64,365.54,770.64,313.53,794.93,845.54,266.93,992.73,716.63,351.23,573.13,381.52,879.92,428.93,065.42,7712,423.30000
Gross Profit Ratio 0.4890.4950.7340.7510.7530.7270.7230.7230.7050.6390.7740.7380.7710.7130.7750.7830.7710.6770.740.7410.7670.6940.7980.8240.8350.8230.8130.7980.8020.8070.80.7740.7890.7780.7560.7730.7360.6870.7520.7450.7530000
Reseach & Development Expenses 510500520500550630610590540593.4510490450389.1400290310501.7350400400400.2450500410482.4430480470363.34503700364.726000290.70000000
General & Administrative Expenses 02,233.80001,7820001,720.60001,4820001,3150001,256.70001,177.8000825.3000777.7000606.80000000
Selling & Marketing Expenses 044.900050.200047.800016.20001400013.400017.100035.8000115.6000101.50000000
SG&A 2,119.42,278.72,059.82,093.92,132.11,832.22,424.82,368.71,829.41,768.41,621.91,600.81,531.31,498.21,361.61,305.31,357.91,3291,203.81,174.11,183.21,270.11,127.81,057.51,047.81,194.9952.2894.2866.8861.1774.4721.6703.2893.3649.1638.3591.9708.3520.7478.5459.70000
Other Expenses -2,447.3158.494.8-2,508.7317.5-94349.3403.5327.6-709.1240.3295.4326.3-178.554.848.5131.2-286.3146.4132.276.4-18344.1152.481.352.4151.591.847.623.990.966.624.150.51628.730.2-94.945.426.825.60000
Operating Expenses 2,629.42,778.75,235.92,559.85,3104,783.65,661.95,147.14,805.33,362.54,409.94,212.93,8702,703.43,675.23,146.33,1992,956.13,197.53,219.43,2382,136.52,985.82,994.52,865.43,136.62,945.42,621.72,654.52,420.72,640.12,3022,180.92,047.92,052.21,952.91,757.41,229.81,732.81,6101,576.60000
Operating Income 2,963.82,440.72,9342,782.82,481.31,531.81,711.82,039.91,899.81,7942,078.62,312.81,893.32,385.82,125.42,459.21,9521,481.61,623.71,544.41,4561,170.4886.41,487.31,403.21,228.91,825.21,691.81,140.41,424.81,626.81,690.71,535.71,303.31,520.91,428.61,122.51,199.11,332.61,161846.70000
Operating Income Ratio 0.2590.2320.2650.2710.2430.1740.1760.2170.20.2210.2480.2610.2530.3340.2840.3440.2920.2260.2490.240.2380.2460.1830.2730.2750.2320.3110.3130.2410.2990.3050.3280.3260.3030.3220.3260.2870.3390.3270.3120.2630000
Total Other Income Expenses Net 257.4339.7-24.9-23.4209.1-11.3-28.4-9.9318.8182.7230.8291.4311.2-9829.333.2114.9277127.371.258.5-78.543.2151.179.651.3150.190.946.915183.7-39.544.539.3-2.743.454.1-50.215.229.326.40000
Income Before Tax 3,221.22,780.42,909.12,759.42,690.41,520.51,683.42,0302,218.61,976.72,309.42,604.22,204.52,287.82,154.72,492.42,066.91,758.61,7511,615.61,514.51,091.9929.61,638.41,482.81,280.21,975.31,782.71,187.31,439.81,810.51,651.21,580.21,342.61,518.21,4721,176.61,148.91,347.81,190.3873.10000
Income Before Tax Ratio 0.2810.2640.2630.2680.2630.1720.1730.2160.2330.2430.2760.2940.2950.320.2880.3480.3090.2680.2690.2510.2470.2290.1920.3010.290.2410.3360.330.2510.3020.340.320.3350.3120.3210.3360.3010.3250.330.320.2710000
Income Tax Expense 763.5753.2808.8806.4609.2298338.3464472.4464.6391.6644.8467695.2388.4790.2589.3467675.5452368.2203260.6384.5424.9335.3500.6463.8239.4299.6384.5344.6384.7253405.2472.4338.2407.5417.2360.3276.50000
Net Income 2,457.72,027.22,100.31,9532,081.21,222.51,345.11,5661,746.21,512.11,917.81,959.41,737.51,592.61,766.31,702.21,477.61,291.61,075.51,163.61,146.3888.96691,253.91,057.9944.91,474.71,318.9947.91,140.21,4261,306.61,195.51,089.61,113999.6838.4741.4930.6830596.60000
Net Income Ratio 0.2150.1920.190.190.2040.1390.1380.1670.1840.1860.2290.2210.2320.2230.2360.2380.2210.1970.1650.1810.1870.1870.1380.230.2070.1780.2510.2440.20.2390.2670.2530.2540.2530.2350.2280.2140.210.2280.2230.1850000
EPS 19.5416.116.6815.5116.539.7110.512.2213.6311.714.7815.113.3912.2713.6113.0111.299.878.228.898.766.795.079.58.017.1611.179.997.188.6410.799.99.058.258.637.846.525.677.056.294.534.333.712.492.23
EPS Diluted 19.5316.0916.6715.516.539.7110.512.2213.6311.714.7715.113.3912.2713.611311.299.878.218.898.766.795.079.58.017.1611.179.997.188.6310.799.99.058.258.637.836.515.677.056.294.524.333.72.492.22
EBITDA 3,303.52,783.23,276.63,119.93,030.71,8622,044.82,366.92,545.22,361.62,636.12,923.62,528.42,619.42,471.62,7912,363.42,244.92,006.11,908.61,760.21,287.11,117.21,814.61,656.21,447.72,126.51,929.11,322.21,637.91,971.71,798.81,720.31,4681,650.81,592.41,291.41,348.31,4931,332.31,014.30000
EBITDA Ratio 0.2890.2640.2960.3030.2970.2110.210.2520.2680.290.3150.330.3380.3670.330.390.3540.3420.3080.2970.2880.270.230.3330.3240.2730.3620.3570.2790.3440.370.3490.3650.3410.3490.3640.330.3810.3660.3580.3150000